These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 13260554)

  • 1. Dissociated depigmentation in vitiligo; significance and therapeutic implications.
    PEGUM JS
    Br J Dermatol; 1955 Oct; 67(10):348-50. PubMed ID: 13260554
    [No Abstract]   [Full Text] [Related]  

  • 2. Vitiligo-like depigmentation in patients receiving programmed cell death-1 inhibitor reflects active vitiligo.
    Fukuda K; Harris JE
    J Am Acad Dermatol; 2018 Jan; 78(1):e15-e16. PubMed ID: 29241799
    [No Abstract]   [Full Text] [Related]  

  • 3. Vitiligo-like manifestations of graft-versus-host disease in a pediatric population.
    Dai J; Hight RS; Grullon K; Xiao TL; Stein SL
    Pediatr Dermatol; 2023 Jan; 40(1):157-161. PubMed ID: 36063124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Confetti-like depigmentation: A potential sign of rapidly progressing vitiligo.
    Sosa JJ; Currimbhoy SD; Ukoha U; Sirignano S; O'Leary R; Vandergriff T; Hynan LS; Pandya AG
    J Am Acad Dermatol; 2015 Aug; 73(2):272-5. PubMed ID: 26054430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Increased depigmentation in vitiligo after roentgen irradiation].
    SCHMITT HG
    Strahlentherapie; 1955 May; 97(1):159-60. PubMed ID: 13246889
    [No Abstract]   [Full Text] [Related]  

  • 6. Treatment with Modified Heat Shock Protein Repigments Vitiligo Lesions in Sinclair Swine.
    Frisoli ML; Harris JE
    J Invest Dermatol; 2018 Dec; 138(12):2505-2506. PubMed ID: 30466536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vitiligo-like depigmentation patterns in patients receiving immunotherapy for metastatic melanoma.
    Zottarelli F; Giorgione R; Gironi LC; Farinelli P; Sponghini AP; Rondonotti D; Savoia P
    Ital J Dermatol Venerol; 2021 Feb; 156(1):97-99. PubMed ID: 30350560
    [No Abstract]   [Full Text] [Related]  

  • 8. Immunological basis of melanoma-associated vitiligo-like depigmentation.
    González R; Torres-López E
    Actas Dermosifiliogr; 2014 Mar; 105(2):122-7. PubMed ID: 23146137
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CCL22 to Activate Treg Migration and Suppress Depigmentation in Vitiligo.
    Eby JM; Kang HK; Tully ST; Bindeman WE; Peiffer DS; Chatterjee S; Mehrotra S; Le Poole IC
    J Invest Dermatol; 2015 Jun; 135(6):1574-1580. PubMed ID: 25634358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemical-Induced Vitiligo.
    Harris JE
    Dermatol Clin; 2017 Apr; 35(2):151-161. PubMed ID: 28317525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Presentations, Signs of Activity, and Differential Diagnosis of Vitiligo.
    Goh BK; Pandya AG
    Dermatol Clin; 2017 Apr; 35(2):135-144. PubMed ID: 28317523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vitiligo-like depigmentation as a presenting sign of metastatic melanoma.
    Kiecker F; Hofmann M; Sterry W; Trefzer U
    J Eur Acad Dermatol Venereol; 2006 Oct; 20(9):1135-7. PubMed ID: 16987274
    [No Abstract]   [Full Text] [Related]  

  • 13. Vitiligo-like depigmentation in patients with stage III-IV melanoma receiving immunotherapy and its association with survival: a systematic review and meta-analysis.
    Teulings HE; Limpens J; Jansen SN; Zwinderman AH; Reitsma JB; Spuls PI; Luiten RM
    J Clin Oncol; 2015 Mar; 33(7):773-81. PubMed ID: 25605840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monobenzone-induced depigmentation: from enzymatic blockade to autoimmunity.
    van den Boorn JG; Melief CJ; Luiten RM
    Pigment Cell Melanoma Res; 2011 Aug; 24(4):673-9. PubMed ID: 21689385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regressing cutaneous malignant melanoma and vitiligo-like depigmentation.
    Arpaia N; Cassano N; Vena GA
    Int J Dermatol; 2006 Aug; 45(8):952-6. PubMed ID: 16911383
    [No Abstract]   [Full Text] [Related]  

  • 16. A comparative pilot study of dipstick versus open-spray cryotherapy techniques as depigmentation treatments for vitiligo.
    Abdallah M; Saleh HM
    J Cosmet Dermatol; 2022 Apr; 21(4):1772-1773. PubMed ID: 34216083
    [No Abstract]   [Full Text] [Related]  

  • 17. Depigmentation patterns of nonsegmental vitiligo: a prospective study of macromorphologic changes in lesions.
    Menchini G; Comacchi C; Cappugi P; Torchia D
    Am J Clin Dermatol; 2013 Feb; 14(1):55-9. PubMed ID: 23329080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral manifestations of vitiligo.
    Nagarajan A; Masthan MK; Sankar LS; Narayanasamy AB; Elumalai R
    Indian J Dermatol; 2015; 60(1):103. PubMed ID: 25657420
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A mouse model of vitiligo induced by monobenzone.
    Zhu Y; Wang S; Xu A
    Exp Dermatol; 2013 Jul; 22(7):499-501. PubMed ID: 23800067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Excimer light therapy for the treatment of residual depigmentation after at least six months of surgical grafting techniques in stable vitiligo: Results of a retrospective case series.
    Yadav D; Gupta S
    Indian J Dermatol Venereol Leprol; 2022; 88(5):671-674. PubMed ID: 35962519
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.